USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) CFO G Doug Iiekking sold 4,548 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
USANA Health Sciences Trading Up 0.8%
Shares of USANA Health Sciences stock traded up $0.24 during mid-day trading on Friday, hitting $30.25. 154,398 shares of the stock were exchanged, compared to its average volume of 131,057. The company has a 50-day simple moving average of $27.08 and a 200 day simple moving average of $32.46. The stock has a market capitalization of $563.35 million, a price-to-earnings ratio of 10.69, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $49.78.
USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million during the quarter, compared to analysts' expectations of $243.08 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the previous year, the company earned $0.86 EPS. Equities research analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.
Institutional Trading of USANA Health Sciences
Several large investors have recently bought and sold shares of the company. US Bancorp DE boosted its stake in shares of USANA Health Sciences by 13.1% in the first quarter. US Bancorp DE now owns 4,611 shares of the company's stock valued at $124,000 after purchasing an additional 535 shares during the period. Exchange Traded Concepts LLC lifted its holdings in USANA Health Sciences by 7.1% in the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock worth $248,000 after buying an additional 606 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in USANA Health Sciences by 339.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock valued at $27,000 after buying an additional 771 shares during the last quarter. R Squared Ltd acquired a new stake in shares of USANA Health Sciences during the fourth quarter valued at about $28,000. Finally, Martingale Asset Management L P increased its position in shares of USANA Health Sciences by 5.4% during the first quarter. Martingale Asset Management L P now owns 17,542 shares of the company's stock worth $473,000 after acquiring an additional 900 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.
Analysts Set New Price Targets
USNA has been the subject of a number of research reports. StockNews.com cut shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Sidoti lowered USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, February 18th. Finally, DA Davidson dropped their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research report on Thursday, February 27th.
View Our Latest Stock Analysis on USNA
About USANA Health Sciences
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories

Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.